Experimental Weight–Loss Drug Seems to Work: Study

Qnexa was recently turned down as a weight–loss aid by the US Food and Drug Administration, because there was not enough data on the risk of birth defects and heart problems related to the drug. Topiramate has been linked to an increased risk for cleft …
See all stories on this topic »